Physician profile
John A Panozzo
NPI 1841238029
$28,546.22
in general payments reported to CMS, 2019-2025
72 companies · $4,508 in 2025
The $4,508 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,844 · 2020: $3,562 · 2021: $4,469 · 2022: $3,420 · 2023: $3,467 · 2024: $4,276 · 2025: $4,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $41.52 · Long Term Medical Supply Or Device Loan: $19.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,189.63 |
| Education | $41.52 |
| Long Term Medical Supply Or Device Loan | $19.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $3,480.53 | 2019-2025 | Eliquis |
| Abbvie INC. | $2,900.51 | 2019-2025 | |
| Novo Nordisk INC | $1,946.89 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $1,626.59 | 2019-2025 | Repatha, Prolia, Evenity |
| Astrazeneca Pharmaceuticals LP | $1,429.14 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Biohaven Pharmaceuticals, INC. | $1,380.92 | 2021 | |
| Lilly USA, LLC | $1,367.26 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,310.59 | 2019-2025 | Jardiance, Synjardy |
| Pfizer INC. | $1,207.90 | 2019-2025 | |
| Esperion Therapeutics, INC. | $822.12 | 2020-2025 | Nexletol, Nexlizet |
| Phathom Pharmaceuticals, INC. | $787.22 | 2024-2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $751.48 | 2019-2025 | |
| Glaxosmithkline, LLC. | $658.04 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lundbeck LLC | $633.24 | 2020-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $531.78 | 2019-2025 | Xifaxan, Cycloset, Relistor |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $528.66 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $523.98 | 2019-2023 | Spravato |
| Allergan, INC. | $488.98 | 2019-2020 | |
| Corcept Therapeutics | $470.52 | 2024-2025 | Korlym |
| Aimmune Therapeutics, INC. | $425.87 | 2024-2025 | Zenpep |
| Azurity Pharmaceuticals, INC. | $416.64 | 2023-2025 | Horizant, Edarbi, Horizant |
| Takeda Pharmaceuticals U.S.A., INC. | $414.54 | 2019-2025 | Trintellix |
| Kowa Pharmaceuticals America, INC. | $413.72 | 2019-2025 | Seglentis, Livalo, Zoryve |
| Mylan Specialty L.P. | $311.57 | 2020-2024 | Yupelri |
| Arbor Pharmaceuticals, INC. | $267.66 | 2020-2021 | |
| Radius Health, INC. | $265.52 | 2024-2025 | Tymlos |
| Abbott Laboratories | $260.52 | 2021-2024 | Freestyle Libre 3, Freestyle Insulinx |
| Merck Sharp & Dohme LLC | $258.41 | 2019-2025 | Gardasil 9, Capvaxive, Belsomra |
| Otsuka America Pharmaceutical, INC. | $253.85 | 2023-2024 | Rexulti |
| Axsome Therapeutics, INC. | $239.34 | 2022-2025 | Auvelity, Symbravo |
| Preventric Diagnostics, INC. | $191.32 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $174.95 | 2022 | |
| Exact Sciences Corporation | $165.97 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Ibsa Pharma INC. | $163.46 | 2019-2025 | Flector, Licart, Tirosint |
| Eisai INC. | $140.64 | 2020-2022 | |
| Edwards Lifesciences Corporation | $128.04 | 2019-2025 | Sapien 3 Ultra Resilia |
| Lucid Diagnostics INC. | $84.46 | 2022-2024 | |
| Catalyst Pharmaceuticals, INC. | $83.97 | 2022 | |
| Vanda Pharmaceuticals INC. | $82.94 | 2024-2025 | Fanapt |
| Agios Pharmaceuticals, INC. | $64.05 | 2025 | Pyrukynd |
| Insulet Corporation | $59.70 | 2020-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $57.05 | 2019-2025 | |
| Dexcom, INC. | $52.92 | 2023-2025 | Dexcom G6 Transmitter |
| Corium, LLC | $49.93 | 2023 | Adlarity |
| Amarin Pharma, INC. | $49.86 | 2019-2022 | |
| Phadia US INC. | $45.22 | 2019-2023 | Immunocap |
| Viatris Specialty LLC | $44.39 | 2025 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $42.17 | 2019 | |
| Harmony Biosciences LLC | $40.04 | 2024 | |
| Recordati_rare_diseases_inc. | $39.56 | 2025 | Isturisa |
| Endo Pharmaceuticals INC. | $30.94 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $30.27 | 2024-2025 | Caplyta |
| Janssen Biotech, INC. | $28.55 | 2019 | |
| Amneal Pharmaceuticals LLC | $28.15 | 2021-2022 | |
| Horizon Therapeutics Plc | $27.63 | 2021-2022 | |
| Seqirus USA INC | $22.01 | 2024 | Flucelvax, Fluad |
| Sanofi Pasteur INC. | $19.56 | 2023 | |
| Ferring Pharmaceuticals INC. | $18.63 | 2019 | |
| Biogen, INC. | $18.25 | 2019 | |
| Acella Pharmaceuticals, LLC | $17.99 | 2024 | NP Thyroid 60 |
| Inspire Medical Systems, INC. | $16.90 | 2024 | Inspire |
| Adlon Therapeutics L.P. | $16.82 | 2020 | |
| Theracosbio, LLC | $15.88 | 2024 | Brenzavvy |
| Shield Therapeutics INC | $15.77 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $15.66 | 2023 | Airduo Digihaler |
| Philips North America LLC | $14.15 | 2024 | (Ck7) Extended Holter |
| Currax Pharmaceuticals LLC | $13.83 | 2021 | |
| Boston Scientific Corporation | $13.31 | 2021 | |
| Vistapharm, INC. | $12.80 | 2021 | |
| Melinta Therapeutics, LLC | $11.89 | 2019 | |
| Csl Behring | $11.68 | 2019 | |
| Hikma Pharmaceuticals USA | $10.92 | 2019 |
Drugs and devices associated with these payments
Rexulti $830Voquezna $787Jardiance $614Nexletol $563Nurtec Odt $546Mounjaro $544Breztri $496Vraylar $489Korlym $471Zenpep $418Ubrelvy $411Kerendia $401Zepbound $391Qulipta $333Repatha $329Leqvio $304Horizant $296Creon $286Tymlos $266Prolia $263Rybelsus $260Ozempic $260Zavzpret $258Otezla $252Trintellix $248Yupelri $247Evenity $242Trelegy Ellipta $232Linzess $204Eliquis $190Xifaxan $174Seglentis $165Auvelity $156Livalo $147Freestyle Libre 3 $146Prevnar 20 $131Nexlizet $120Arexvy $114Shingrix $113Comirnaty $108Abrysvo $108Edarbi $101Cologuard Collection Kit $87.84Wegovy $87.81Airsupra $83.08Fanapt $82.94The Cologuard Plus Collection Kit $78.13Entresto $65.67Farxiga $65.26Pyrukynd $64.05Symbravo $57.61Dexcom G6 Transmitter $52.92Adlarity $49.93Capvaxive $46.11Gardasil 9 $46.11Omnipod $42.41Synjardy $41.52Cycloset $41.47Wakix $40.04Isturisa $39.56Belsomra $36.16Relistor $35.49Viberzi $34.21Tzield $33.85Flector $32.62Licart $32.62Tirosint $32.62Zoryve $32.43Sapien 3 Ultra Resilia $30.32Caplyta $30.27Kisunla $28.52Paxlovid $28.14Emgality $26.48Trulicity $22.18Flucelvax $22.01Fluad $22.01Gardasil $21.78Synthroid $21.31Azmiro $20.42Freestyle Insulinx $19.98Fluzone High-Dose $19.56Flublok Quadrivalent Northern Hemisphere $19.56Fluzone Quadrivalent Northern Hemisphere $19.56NP Thyroid 60 $17.99Immunocap $17.78Spravato $17.39Inspire $16.90Dalvance $16.56Brenzavvy $15.88Accrufer $15.77Trulance $15.77Airduo Digihaler $15.66(Ck7) Extended Holter $14.15Nucala $13.99Vowst $7.60
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Panozzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.